RELX reports 7% growth and reaffirms outlook for RELX stock

Published on 10/26/2026 at 10:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Legal revenue grew 10% in the first nine months of 2026. RELX stock costs EUR 36.21 on October 26, 2026, 0.25% below the Xetra close.

Growth and trading context

RELX reported 7 percent underlying revenue growth for the first nine months of 2026 on October 22, 2026.
Legal delivered 10 percent underlying revenue growth, ahead of Risk at 8 percent and STM at 6 percent.
RELX stock trades at EUR 36.21 at 10:43 a.m. CET at Lang & Schwarz on October 26, 2026, 0.25 percent below the Xetra close of October 23, 2026.

Schwarzweiß-Reportagefoto eines Bibliotheksarchivs mit Forscher, Sinnbild für RELX plc — RELX plc (ISIN GB00B2B0DG97) sammelt wissenschaftliche Fachliteratur, wie diese dokumentarische Archiv-Szene symbolisch zeigt, Illustration mit AI erstellt.

RELX (ISIN GB00B2B0DG97) reported 7 percent underlying revenue growth for the first nine months of 2026 and reaffirmed its full-year outlook in an October 22, 2026 trading update published by Investegate. RELX stock was EUR 36.21 at Lang & Schwarz on October 26, 2026 at 10:43 a.m. CET, down 0.25 percent from the EUR 36.30 Xetra close of October 23, 2026.

Legal leads the growth mix

The update showed a clear split across RELX's divisions. Legal delivered 10 percent underlying revenue growth in the first nine months of 2026, while Risk grew 8 percent and Scientific, Technical & Medical advanced 6 percent, according to Investegate. Exhibitions grew 4 percent as disruption in the Middle East moderated its performance.

For investors, the important comparison is between the 7 percent group-wide growth rate and the 10 percent Legal result. The stronger Legal contribution supports RELX's shift toward analytics and decision tools, while the Exhibitions figure shows where external disruption is still affecting the mix.

What comes next for RELX?

The company expects another year of strong underlying revenue and adjusted operating profit growth, alongside strong adjusted earnings per share growth on a constant-currency basis. The next substantiated company date is November 3, 2026, when RELX is scheduled to hold an investor seminar focused on Scientific, Technical & Medical operations, as stated in the Investing.com transcript.

Trading remains close to Friday's close

RELX is a global provider of information-based analytics and decision tools, serving professional and business customers through Risk, Scientific, Technical & Medical, Legal, and Exhibitions. The company says it employs more than 37,000 people and trades in London under ticker REL, according to its RELX investor overview.

Its market capitalization was EUR 63.0 billion at the October 23, 2026 close. The stock's modest move below the Xetra close leaves the October trading update as the main valuation reference for the session. RELX was trading at EUR 36.21 at Lang & Schwarz on October 26, 2026 at 10:43 a.m. CET, 0.25 percent below the Xetra close of October 23, 2026 at EUR 36.30. The further course of trading is shown by the continuously updated real-time quote of RELX stock.